Similar articles

• Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.

  Schneerson R, Robbins JB. Schneerson R, et al. N Engl J Med. 1975 May 22;292(21):1093-6. doi: 10.1056/NEJM197505222922103. N Engl J Med. 1975. PMID: 48191 Clinical Trial.
• Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

  Robbins JB, Parke JC Jr, Schneerson R, Whisnant JK. Robbins JB, et al. Pediatr Res. 1973 Mar;7(3):103-10. doi: 10.1203/00006450-197303000-00001. Pediatr Res. 1973. PMID: 4120458 No abstract available.
• Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B.

  Insel RA, Anderson PW Jr. Insel RA, et al. J Immunol. 1982 Mar;128(3):1267-70. J Immunol. 1982. PMID: 7035561
• Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers.

  Anderson PW Jr, Stein EC, Insel RA. Anderson PW Jr, et al. Contrib Microbiol Immunol. 1989;10:115-24. Contrib Microbiol Immunol. 1989. PMID: 2684504 Review. No abstract available.
• Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.

  Sood SK, Daum RS. Sood SK, et al. Pediatrics. 1990 Apr;85(4 Pt 2):698-704. Pediatrics. 1990. PMID: 2107522 Review.